CHARACTERIZATION OF CD38 EXPRESSION IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) PATIENTS

被引:0
作者
Buson, E. [1 ,2 ]
Calabretto, G. [1 ,2 ]
Burattin, A. [4 ]
Gasparini, V. R. [1 ,2 ]
Orsi, S. [4 ]
Rampazzo, E. [1 ,2 ]
Teramo, A. [1 ,2 ]
Trimarco, V. [1 ]
Manni, S. [1 ,2 ]
Barila, G. [1 ,3 ]
Facco, M. [1 ,2 ]
Bortoluzzi, S. [4 ]
Trentin, L. [1 ]
Semenzato, G. [1 ,2 ]
Zambello, R. [1 ,2 ]
机构
[1] Padova Univ, Sch Med, Dept Med, Hematol Div, Padua, Italy
[2] Veneto Inst Mol Med VIMM, Padua, Italy
[3] Vicenza Hosp, Hematol Div, Vicenza, Italy
[4] Univ Padua, Dept Mol Med, Padua, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P068
引用
收藏
页码:91 / 91
页数:1
相关论文
共 50 条
  • [41] PROGNOSTIC VALUE OF T-CELL CD38 EXPRESSION IN B-CHRONIC LYMPHOCYTIC LEUKEMIA
    Abousamra, Nashwa
    El-Din, Manal Salah
    Azmy, Emad
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2011, 80B (06) : 414 - 414
  • [42] T-cell prolymphocytic leukemia
    Claire E. Dearden
    Medical Oncology, 2006, 23 : 17 - 22
  • [43] T-cell prolymphocytic leukemia
    Khot, Amit
    Dearden, Claire
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 365 - 371
  • [44] EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
    W. Wiktor-Jedrzejczak
    J. Drozd-Sokolowska
    D. J. Eikema
    J. Hoek
    M. Potter
    G. Wulf
    L. Sellner
    P. Ljungman
    P. Chevallier
    L. Volin
    Y. Koc
    S. Martin
    D. Bunjes
    M. Rovira
    M. Itälä-Remes
    R. Foá
    E. Deconinck
    T. Gedde-Dahl
    J. Cornelissen
    M. Collin
    A. Brecht
    A. Patel
    M. de Groot
    P. Reményi
    A. Nagler
    J. Finke
    P. Turlure
    S. Iacobelli
    A. van Biezen
    J. Schetelig
    N. Kröger
    P. Dreger
    Bone Marrow Transplantation, 2019, 54 : 1391 - 1398
  • [45] T-cell Prolymphocytic Leukemia
    Sud, Amit
    Dearden, Claire
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (02) : 273 - +
  • [46] T-Cell Prolymphocytic Leukemia
    Dearden, Claire E.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S239 - S243
  • [47] T-cells with extremely short telomeres and high telomerase activity in T-cell prolymphocytic leukemia (T-PLL): The ideal target for telomerase inhibition.
    Roeth, Alexander
    Duerig, Jan
    Himmelreich, Heike
    Siebert, Reiner
    Bug, Stefanie
    Duehrsen, Ulrich
    Lansdorp, Peter M.
    Baerlocher, Gabriela
    BLOOD, 2006, 108 (11) : 150A - 151A
  • [48] T-cell prolymphocytic leukemia
    Dearden, CE
    MEDICAL ONCOLOGY, 2006, 23 (01) : 17 - 22
  • [49] EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)
    Wiktor-Jedrzejczak, W.
    Drozd-Sokolowska, J.
    Eikema, D. J.
    Hoek, J.
    Potter, M.
    Wulf, G.
    Sellner, L.
    Ljungman, P.
    Chevallier, P.
    Volin, L.
    Koc, Y.
    Martin, S.
    Bunjes, D.
    Rovira, M.
    Itala-Remes, M.
    Foa, R.
    Deconinck, E.
    Gedde-Dahl, T.
    Cornelissen, J.
    Collin, M.
    Brecht, A.
    Patel, A.
    de Groot, M.
    Remenyi, P.
    Nagler, A.
    Finke, J.
    Turlure, P.
    Iacobelli, S.
    van Biezen, A.
    Schetelig, J.
    Kroeger, N.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2019, 54 (09) : 1391 - 1398
  • [50] Indolent T-cell prolymphocytic leukemia with no expression of surface T-cell receptors or surface CD3
    Wang, Huan-You
    Murray, Sarah S.
    Bejar, Rafael
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (04) : E224 - E226